Concise Review

You have full text access to this OnlineOpen article

Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence

  1. Andreas Cerny1,
  2. Francis V. Chisari M.D. MD2,*

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510300312

Issue

Hepatology

Hepatology

Volume 30, Issue 3, pages 595–601, September 1999

Additional Information

How to Cite

Cerny, A. and Chisari, F. V. (1999), Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence. Hepatology, 30: 595–601. doi: 10.1002/hep.510300312

Author Information

  1. 1

    Department of Internal Medicine, Inselspital, University of Berne, Berne, Switzerland

  2. 2

    Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA

*Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037. Fax: (619) 784-2160

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003
  3. Manuscript Accepted: 21 MAY 1999
  4. Manuscript Received: 2 MAR 1999

Funded by

  • National Institutes of Health to F.V.C. Grant Numbers: AI20001, CA40489, CA54560, CA76403, M01-RR00833
  • Swiss National Science Foundation (A.C.). Grant Numbers: 31-37291.93, 32-52915.97
  • Bonizzi-Theler Foundation
  • Sandoz Foundation,
  • Helmut Horten Foundation
  • Desirée
  • Niels Yde Foundation
  • European Community. Grant Number: (Biomed PL-951064)
  • Central Laboratory Blood Transfusion Service of the Swiss Red Cross

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (94K)

References

  • 1
    Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359–362. MEDLINE
  • 2
    Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990; 46:423–441. MEDLINE
  • 3
    Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26:62S–65S. MEDLINE
    Direct Link:
  • 4
    Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73:673–679. MEDLINE
  • 5
    Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, et al. A proposed system for the nomenclature of hepatitis C viral genotypes [Letter]. Hepatology 1994; 19:1321–1324. MEDLINE
    Direct Link:
  • 6
    Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66:3225–3229. MEDLINE
  • 7
    Simmonds P. Variability of the hepatitis C virus genome. Curr Stud Hematol Blood Transfus 1998; 62:38–63. MEDLINE
  • 8
    Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, et al. Binding of hepatitis C virus to CD81. Science 1998; 282:938–941. MEDLINE
  • 9
    Yanagi M, Purcell RH, Emerson SU, Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A 1997; 94:8738–8743. MEDLINE
  • 10
    Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997; 277:570–574. MEDLINE
  • 11
    Shindo M, DiBisceglie AM, Biswas R, Mihalik K, Feinstone SM. Hepatitis C virus replication during acute infection in the chimpanzee. J Infect Dis 1992; 166:424–427. MEDLINE
  • 12
    Erickson AL, Houghton M, Choo QL, Weiner AJ, Ralston R, Muchmore E, Walker CM. Hepatitis C virus–specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol 1993; 151:4189–4199. MEDLINE
  • 13
    Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258:135–140. MEDLINE
  • 14
    Wyatt CA, Andrus L, Brotman B, Huang F, Lee DH, Prince AM. Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection. J Virol 1998; 72:1725–1730. MEDLINE
  • 15
    Zinkernagel RM, Haenseler E, Leist T, Cerny A, Hengartner H, Althage A. T cell–mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I–restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? J Exp Med 1986; 164:1075–1092. MEDLINE
  • 16
    Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster, et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 1990; 248:361–364. MEDLINE
  • 17
    Guidotti LG, Chisari FV. To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996; 8:478–483. MEDLINE
  • 18
    Farci P, Alter HJ, Shimoda A, Govindarajan S, Cheung LC, Melpolder JC, Sacher RA, et al. Hepatitis C virus–associated fulminant hepatic failure. N Engl J Med 1996; 335:631–634. MEDLINE
  • 19
    Brillanti S, Foli M, Gaiani S, Masci C, Miglioli M, Barbara L. Persistent hepatitis C viraemia without liver disease. Lancet 1993; 341:464–465. MEDLINE
  • 20
    Tanaka S, Takenaka K, Matsumata T, Mori R, Sugimachi K. Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers. Dig Dis Sci 1996; 41:208–215. MEDLINE
  • 21
    Gruber A, Lundberg LG, Bjorkholm M. Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy. J Intern Med 1993; 234:223–225. MEDLINE
    Direct Link:
  • 22
    Fan FS, Tzeng CH, Hsiao KI, Hu ST, Liu WT, Chen PM. Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant 1991; 8:417–420. MEDLINE
  • 23
    Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis [published erratum appears in J Immunol 1993 Mar 15;150(6):2563]. J Immunol 1992; 149:3339–3344. MEDLINE
  • 24
    Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, Brunetto MR, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993; 178:17–25. MEDLINE
  • 25
    Liaw YF, Lee CS, Tsai SL, Liaw BW, Chen TC, Sheen IS, Chu CM. T-cell–mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995; 22:1368–1373. MEDLINE
  • 26
    Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321:1494–1500. MEDLINE
  • 27
    Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994; 343:388–390. MEDLINE
  • 28
    Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A 1996; 93:15394–15399. MEDLINE
  • 29
    Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A 1996; 93:1759–1763. MEDLINE
  • 30
    Agnello V. Mixed cryoglobulinemia and hepatitis C virus. ; quiz 92 Hosp Pract (Off Ed) 1995; 30:35–42. MEDLINE
  • 31
    Barcy S, Wettendorff M, Leo O, Urbain J, Kruger M, Ceuppens JL, de Boer M. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity. Int Immunol 1995; 7:179–189. MEDLINE
  • 32
    Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U, Zauli D, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335:258–259. MEDLINE
  • 33
    Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 1989; 83:1066–1072. MEDLINE
  • 34
    Cerny A. Pathogenetic relevance of LKM-3 autoantibodies in chronic hepatitis D [Letter; comment]. Lancet 1994; 344:1369–1370. MEDLINE
  • 35
    Gerotto M, Pontisso P, Giostra F, Francesconi R, Muratori L, Ballardini G, Lenzi M, et al. Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies. J Hepatol 1994; 21:273–276. MEDLINE
  • 36
    Lindgren S, Braun HB, Michel G, Nemeth A, Nilsson S, Thome-Kromer B, Eriksson S. Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C–related chronic liver disease in Sweden. Swedish Internal Medicine Liver club. Scand J Gastroenterol 1997; 32:175–178. MEDLINE
  • 37
    Lenzi M, Frisoni M, Mantovani V, Ricci P, Muratori L, Francesconi R, Cuccia M, et al. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 1998; 91:2062–2066. MEDLINE
  • 38
    Koszinowski UH, Reddehase MJ, Jonjic S. The role of CD4 and CD8 T cells in viral infections. Curr Opin Immunol 1991; 3:471–475. MEDLINE
  • 39
    Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138–146. MEDLINE
  • 40
    Hoffmann RM, Diepolder HM, Zachoval R, Zwiebel FM, Jung MC, Scholz S, Nitschko H, et al. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995; 21:632–638. MEDLINE
  • 41
    Leroux-Roels G, Esquivel CA, De Leys R, Stuyver L, Elewaut A, Philippe J, Desombere I, et al. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa. Hepatology 1996; 23:8–16. MEDLINE
    Direct Link:
  • 42
    Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994; 19:286–295. MEDLINE
    Direct Link:
  • 43
    Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996; 98:706–714. MEDLINE
  • 44
    Diepolder HM, Gerlach JT, Zachoval R, Hoffmann RM, Jung MC, Wierenga EA, Scholz S, et al. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 1997; 71:6011–6019. MEDLINE
  • 45
    Tsai S-L, Liaw Y-F, Chen M-H, Huang C-Y, Kuo GC. Detection of Type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C chronicity. Hepatology 1997; 25:449–458. MEDLINE
    Direct Link:
  • 46
    Diepolder HM, Zachoval R, Hoffmann RM, Jung MC, Gerlach T, Pape GR. The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C. J Mol Med 1996; 74:583–588. MEDLINE
  • 47
    Sachithanandan S, Fielding JF. Jaundice at onset signifies a good prognosis in anti-D-associated HCV infection. Eur J Gastroenterol Hepatol 1997; 9:77–79. MEDLINE
  • 48
    Bertoletti A, D'Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, Missale G, et al. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997; 112:193–199. MEDLINE
  • 49
    Doherty PC, Zinkernagel RM. T-cell–mediated immunopathology in viral infections. Transplant Rev 1974; 19:89–120. MEDLINE
  • 50
    Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993; 67:7522–7532. MEDLINE
  • 51
    Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995; 95:521–530. MEDLINE
  • 52
    Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching WM, et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus–encoded peptides binding to HLA-A2.1 molecules. J Virol 1995; 69:2462–2470. MEDLINE
  • 53
    Kita H, Hiroishi K, Moriyama T, Okamoto H, Kaneko T, Ohnishi S, Yazaki Y, et al. A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein. J Gen Virol 1995; 76:3189–3193. MEDLINE
  • 54
    Wentworth PA, Sette A, Celis E, Sidney J, Southwood S, Crimi C, Stitely S, et al. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int Immunol 1996; 8:651–659. MEDLINE
  • 55
    Kaneko T, Nakamura I, Kita H, Hiroishi K, Moriyama T, Imawari M. Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein. J Gen Virol 1996; 77:1305–1309. MEDLINE
  • 56
    Chang KM, Rehermann B, McHutchison JG, Pasquinelli C, Southwood S, Sette A, Chisari FV. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest 1997; 100:2376–2385. MEDLINE
  • 57
    Koziel MJ, Walker BD. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection. Springer Semin Immunopathol 1997; 19:69–83. MEDLINE
  • 58
    Wong DK, Dudley DD, Afdhal NH, Dienstag J, Rice CM, Wang L, Houghton M, et al. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 1998; 160:1479–1488. MEDLINE
  • 59
    Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Rice CM, Chisari FV. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996; 70:7092–7102. MEDLINE
  • 60
    Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996; 98:1432–1440. MEDLINE
  • 61
    Ferenbach DA, Haydon GH, Rae F, Malcomson RD, Harrison DJ. Alteration in mRNA levels of Fas splice variants in hepatitis C-infected liver. J Pathol 1997; 183:299–304. MEDLINE
    Direct Link:
  • 62
    Okazaki M, Hino K, Fujii K, Kobayashi N, Okita K. Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C. Dig Dis Sci 1996; 41:2453–2458. MEDLINE
  • 63
    King NJ, Kesson AM. Interferon-independent increases in class I major histocompatibility complex antigen expression follow flavivirus infection. J Gen Virol 1988; 69:2535–2543. MEDLINE
  • 64
    Lobigs M, Blanden RV, Mullbacher A. Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell–mediated autoimmunity. Immunol Rev 1996; 152:5–19. MEDLINE
    Direct Link:
  • 65
    Hiroishi K, Kita H, Kojima M, Okamoto H, Moriyama T, Kaneko T, Ishikawa T, et al. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 1997; 25:705–712. MEDLINE
    Direct Link:
  • 66
    Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158:1473–1481. MEDLINE
  • 67
    Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, et al. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus–specific human CTL. J Immunol 1997; 158:5283–5291. MEDLINE
  • 68
    Koziel MJ, Wong DKH, Dudley D, Houghton M, Walker BD. Hepatitis C virus–specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Inf Dis 1997; 176:859–866.
  • 69
    Bassett SE, Brasky KM, Lanford RE. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol 1998; 72:2589–2599. MEDLINE
  • 70
    Zinkernagel RM. Immunology taught by viruses. Science 1996; 271:173–178. MEDLINE
  • 71
    Lam NP, Neumann AU, Gretch DR, Wiley TE, Perelson AS, Layden TJ. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa. Hepatology 1997; 26:226–231. MEDLINE
    Direct Link:
  • 72
    Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998; 282:103–107. MEDLINE
  • 73
    Franco A, Ferrari C, Sette A, Chisari FV. Viral mutations, TCR antagonism and escape from the immune response. Curr Opin Immunol 1995; 7:524–531. MEDLINE
  • 74
    Xu XN, Screaton GR, Gotch FM, Dong T, Tan R, Almond N, Walker B, et al. Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J Exp Med 1997; 186:7–16. MEDLINE
  • 75
    Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182:1223–1230. MEDLINE
  • 76
    Barry M, McFadden G. Virus encoded cytokines and cytokine receptors. Parasitology 1997; 115:S89–100. MEDLINE
  • 77
    Davis-Poynter NJ, Farrell HE. Masters of deception: a review of herpesvirus immune evasion strategies. Immunol Cell Biol 1996; 74:513–522. MEDLINE
  • 78
    Fleming SB, McCaughan CA, Andrews AE, Nash AD, Mercer AA. A homolog of interleukin-10 is encoded by the poxvirus orf virus. J Virol 1997; 71:4857–4861. MEDLINE
  • 79
    Hengel H, Koszinowski UH. Interference with antigen processing by viruses. Curr Opin Immunol 1997; 9:470–476. MEDLINE
  • 80
    Chen CM, You L-R, Hwang L-H, Lee Y-HW. Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-β receptor modulates the signal pathway of the lymphotoxin-β receptor. J Virol 1997; 71:9417–9429. MEDLINE
  • 81
    Matsumoto M, Hsie T-Y, Zhu N, Vanarsdale T, Hwang SB, Jeng K-S, Gorbalenya AE, et al. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-β receptor. J Virol 1997; 71:1301–1309. MEDLINE
  • 82
    Browning JL, Miatkowski K, Griffiths DA, Bourdon PR, Hession C, Ambrose CM, Meier W. Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxin α and β. J Biol Chem 1996; 271:8616–8626.
  • 83
    Browning JL, Miatkowski K, Sizing I, Griffiths DA, Zafari M, Benjamin CD, Meier W, Mackay F. Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J Exp Med 1996; 183:867–878. MEDLINE
  • 84
    Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C, Lai MMC. Hepatitis C virus core protein binds to the cytoplassmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998; 72:3691–3697. MEDLINE
  • 85
    Ray RB, Meyer K, Shrivastava A, Aggarwaland BB, Ray R. Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein. J Biol Chem 1998; 273:2256–2259. MEDLINE
  • 86
    You L-R, Chen C-M, Lee Y-HW. Hepatitis C virus core protein enhances NF-κB signal pathway triggering by lymphotoxin-β receptor ligand and tumor necrosis factor alpha. J Virol 1999; 73:1672–1681. MEDLINE
  • 87
    Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 1992; 89:3468–3472. MEDLINE
  • 88
    Polyak SJ, Faulkner G, Carithers RL, Corey L, Gretch DR. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis 1997; 175:1101–1107. MEDLINE
  • 89
    Oldstone MB. How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. Virology 1997; 234:179–185. MEDLINE
  • 90
    McMichael AJ, Phillips RE. Escape of human immunodeficiency virus from immune control. Annu Rev Immunol 1997; 15:271–296. MEDLINE
  • 91
    Goulder P, Price D, Nowak M, Rowland-Jones S, Phillips R, McMichael A. Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol Rev 1997; 159:17–29. MEDLINE
    Direct Link:
  • 92
    Shen L, Chen ZW, Letvin NL. The repertoire of cytotoxic T lymphocytes in the recognition of mutant simian immunodeficiency virus variants. J Immunol 1994; 153:5849–5854. MEDLINE
  • 93
    Takahashi H, Merli S, Putney SD, Houghten R, Moss B, Germain RN, Berzofsky JA. A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science 1989; 246:118–121. MEDLINE
  • 94
    Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998; 391:397–401. MEDLINE
  • 95
    Price DA, Goulder PJ, Klenerman P, Sewell AK, Easterbrook PJ, Troop M, Bangham CR, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A 1997; 94:1890–1895. MEDLINE
  • 96
    Ho DD. Perspectives series: host/pathogen interactions. Dynamics of HIV-1 replication in vivo. J Clin Invest 1997; 99:2565–2567. MEDLINE
  • 97
    Weiner AJ, Erickson AL, Kansopon J, Crawford K, Muchmore E, Houghton M, Walker CM. Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection. Princess Takamatsu Symp 1995; 25:227–235. MEDLINE
  • 98
    von Herrath MG, Oldstone MB. Virus-induced autoimmune disease. Curr Opin Immunol 1996; 8:878–885. MEDLINE
  • 99
    Vento S, Cainelli F, Renzini C, Concia E. Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance [Letter]. Lancet 1997; 350:1298–1299. MEDLINE
Get PDF (94K)